Detalhe da pesquisa
1.
Dietary tryptophan metabolite released by intratumoral Lactobacillus reuteri facilitates immune checkpoint inhibitor treatment.
Cell
; 186(9): 1846-1862.e26, 2023 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37028428
2.
Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy.
Oncologist
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38655867
3.
Targeting novel inhibitory receptors in cancer immunotherapy.
Semin Immunol
; 49: 101436, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33288379
4.
The Great Debate at "Melanoma Bridge", Naples, December 7th, 2019.
J Transl Med
; 18(1): 171, 2020 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32299446
5.
Perspectives in melanoma: meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy).
J Transl Med
; 18(1): 346, 2020 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32894202
6.
Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
J Transl Med
; 13: 374, 2015 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-26619946
7.
Radiomic analysis of patient and inter-organ heterogeneity in response to immunotherapies and BRAF targeted therapy in metastatic melanoma.
medRxiv
; 2024 Apr 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38712112
8.
Epitope hierarchy of spontaneous CD4+ T cell responses to LAGE-1.
J Immunol
; 186(1): 312-22, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21131422
9.
Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
J Immunother Cancer
; 11(10)2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37857525
10.
Identification of tumor-intrinsic drivers of immune exclusion in acral melanoma.
bioRxiv
; 2023 Aug 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37662409
11.
Human tumor antigen-specific helper and regulatory T cells share common epitope specificity but exhibit distinct T cell repertoire.
J Immunol
; 184(12): 6709-18, 2010 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20483736
12.
The microbiome: a basis for novel immunomodulation in mice and men.
Clin Adv Hematol Oncol
; 15(7): 535-536, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28749917
13.
Microbiome-derived metabolites counteract tumor-induced immunosuppression and boost immune checkpoint blockade.
Cell Metab
; 34(12): 1903-1905, 2022 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36476933
14.
Facts and Hopes for Gut Microbiota Interventions in Cancer Immunotherapy.
Clin Cancer Res
; 28(20): 4370-4384, 2022 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35748749
15.
Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma.
Front Oncol
; 12: 1022496, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36505793
16.
scMAPA: Identification of cell-type-specific alternative polyadenylation in complex tissues.
Gigascience
; 112022 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488860
17.
Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis.
Clin Epigenetics
; 14(1): 3, 2022 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34991708
18.
Predicting cancer immunotherapy response from gut microbiomes using machine learning models.
Oncotarget
; 13: 876-889, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35875611
19.
Tim-3 mediates T cell trogocytosis to limit antitumor immunity.
J Clin Invest
; 132(9)2022 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35316223
20.
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1.
Nat Med
; 28(3): 545-556, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35228752